Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 101-109 , April 2010

Treatment of the pregnant mother with cancer: A systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors

  • Hatem A. Azim Jr.

      Affiliations

    • Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
    • Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium
    • Corresponding Author InformationCorresponding author. Address: 55 Abdel Monem Riad Street, Mohandeseen, Cairo, Egypt. Tel.: +20 2 33026814; fax: +20 2 33028656.
    • ,
  • Fedro A. Peccatori

      Affiliations

    • Department of Medicine, Division of Hematology–Oncology, European Institute of Oncology, Milan, Italy
    • ,
  • Nicholas Pavlidis

      Affiliations

    • Department of Medical Oncology, Ioannina University, Ioannina, Greece

Received 11 September 2009 ,Revised 5 November 2009 ,Accepted 15 November 2009.

References 

  1. Pentheroudakis G, Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006;42:126–140
  2. Berkowitz GS, Skovron ML, Lapinski RH, Berkowitz RL. Delayed childbearing and the outcome of pregnancy. N Engl J Med. 1990;322:659–664
  3. Loibl S, von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer. 2006;106:237–246
  4. Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:1219–1226
  5. Peccatori FA, Azim HA, Scarfone G, Gadducci A, Bonazzi C, Gentilini O, et al. Weekly epirubicin in the treatment of gestational breast cancer. Breast Cancer Res Treat. 2009;115:591–594
  6. Garcia-Manero M, Royo MP, Espinos J, Pino L, Alcazar JL, Lopez G. Pregnancy associated breast cancer. Eur J Surg Oncol. 2009;35:215–218
  7. Jameel A, Jamil SN. Safety of cytotoxic chemotherapy during pregnancy. J Pak Med Assoc. 2007;57:449–452
  8. Wong AS, Lim EH, Robless PA, Back MF, Wang SC, Ang BK, et al. A pregnant lady with aggressive breast cancer. Ann Acad Med Singapore. 2007;36:448–449
  9. Schotte K, Cocguyt V, Van den Broecke R, Dhondt M, Van Belle S. Breast cancer during pregnancy: cases and review of treatment and prognosis. Acta Clin Belg. 2000;55:102–109
  10. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Int Med. 1992;152:573–576
  11. Dreicer R, Love RR. High total dose 5-fluorouracil treatment during pregnancy. Wis Med J. 1991;90:582–583
  12. Paskulin GA, Gazzola Zen PR, de Camargo Pinto LL, Rosa R, Graziadio C. Combined chemotherapy and teratogenicity. Birth Defects Res A Clin Mol Teratol. 2005;73:634–637
  13. Abellar RG, Pepperell JR, Greco D, Gundogan F, Kostadinov S, Schwartz J, et al. Effects of chemotherapy during pregnancy on the placenta. Pediatr Dev Pathol. 2009;12:35–41
  14. Skrablin S, Banović V, Matković V. Adriamycin and cyclophosphamide chemotherapy in advanced breast cancer in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2007;133:251–252
  15. De Carolis S, Grimolizzi F, Garofalo S, Fatigante G, Ferrazzani S, Carducci B, et al. Cancer in pregnancy: results of a series of 32 patients. Anticancer Res. 2006;26:2413–2418
  16. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol. 2005;23:4192–4197
  17. Peretz B, Peretz T. The effect of chemotherapy in pregnant women on the teeth of offspring. Pediatr Dent. 2003;25:601–604
  18. Meyer-Wittkopf M, Barth H, Emons G, Schmidt S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy. Case report and review of the literature. Ultrasound Obstet Gynecol. 2001;18:62–66
  19. Ginopoulos PV, Michail GD, Kourounis GS. Pregnancy associated breast cancer: a case report. Eur J Gynaecol Oncol. 2004;25:261–263
  20. Müller T, Hofmann J, Steck T. Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;67:197–198
  21. Matsunoki A, Yoshino H, Takayanagi T, Kadoya S, Kotake M, Ishiguro K, et al. Breast cancer during pregnancy-a case report. Gan To Kagaku Ryoho. 2008;35:991–993
  22. Barni S, Ardizzoia A, Zanetta G, Strocchi E, Lissoni P, Tancini G. Weekly doxorubicin chemotherapy for breast cancer in pregnancy. A case report. Tumori. 1992;78:349–350
  23. Eedarapalli P, Biswas N, Coleman M. Epirubicin for breast cancer during pregnancy: a case report. J Reprod Med. 2007;52:730–732
  24. Mathelin C, Annane K, Dufour P, Liegeois P, Bergerat JP. Chemotherapy for breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005;123:260–262
  25. Bedard PL, Cardoso F. Recent advances in adjuvant systemic therapy or early-stage breast cancer. Ann Oncol. 2008;19(Suppl 5):122–127
  26. Potluri V, Lewis D, Burton GV. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clin Breast Cancer. 2006;7:167–170
  27. Nieto Y, Santisteban M, Aramendía JM, Fernández-Hidalgo O, García-Manero M, López G. Docetaxel administered during pregnancy for inflammatory breast carcinoma. Clin Breast Cancer. 2006;6:533–534
  28. Gonzalez-Angulo AM, Walters RS, Carpenter RJ, Ross MI, Perkins GH, Gwyn K, et al. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer. 2004;5:317–319
  29. Lycette JL, Dul CL, Munar M, Belle D, Chiu SY, Koop DR, et al. Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report. Clin Breast Cancer. 2006;7:342–344
  30. Gadducci A, Cosio S, Fanucchi A, Nardini V, Roncella M, Conte PF, et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res. 2003;23:5225–5229
  31. Pereg D, Lishner M. Maternal and fetal effects of systemic therapy in the pregnant woman with cancer. Recent Results Cancer Res. 2008;178:21–38
  32. Bawle EV, Conard JV, Weiss L. Adult and two children with fetal methotrexate syndrome. Teratology. 1998;57:51–55
  33. Peres RM, Sanseverino MT, Guimaraes JL, Coser V, Giuliani L, Moreira RK, et al. Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res. 2001;34:1551–1559
  34. Donnenfeld AE, Pastuszak A, Noah JS, Schick B, Rose NC, Koren G. Methotrexate exposure prior to and during pregnancy. Teratology. 1994;49:79–81
  35. Green FL. Gestational breast cancer: a ten-year experience. South Med J. 1988;81:1509–1511
  36. Cuvier C, Espie M, Extra JM, Marty M. Vinorelbine in pregnancy. Eur J Cancer. 1997;33:168–169
  37. Turchi JJ, Villasis C. Anthracyclines in the treatment of malignancy in pregnancy. Cancer. 1988;61:435–440
  38. Sharma JB, Pushparaj M, Kumar S, Roy KK, Raina V, Malhotra N. Successful pregnancy outcome with 5-flurouracil, epirubicin, cyclophosphamide chemotherapy, and hemostatic radiotherapy with abdominal shielding for metastatic invasive intraduct breast carcinoma. Arch Gynecol Obstet. 2009;279:415–417
  39. Gainford MC, Clemons M. Breast cancer in pregnancy: are taxanes safe?. Clin Oncol (R Coll Radiol). 2006;18:159
  40. De Santis M, Lucchese A, De Carolis S, Ferrazani S, Caruso A. Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer Care. 2000;9:235–237
  41. Sekar R, Stone PR. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol. 2007;110:507–510
  42. Willemse PH, van der Sijde R, Sleijfer DT. Combination chemotherapy and radiation for stage IV breast cancer during pregnancy. Gynecol Oncol. 1990;36:281–284
  43. Tobias JS, Bloom HJ. Doxorubicin in pregnancy. Lancet. 1980;1:776
  44. Minsker DH, Manson JM, Peter CP. Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol. 1993;121:217–223
  45. Djokanovic N, Klieger-Grossmann C, Koren G. Does treatment with bisphosphonates endanger the human pregnancy?. J Obstet Gynaecol Can. 2008;30:1146–1148
  46. Levy S, Fayez I, Taguchi N, Han JY, Aiello J, Matsui D, et al. Pregnancy outcome following in utero exposure to bisphosphonates. Bone. 2009;44:428–430
  47. Azim H, Azim HA. Targeting Her-2/neu in breast cancer: as easy as this!. Oncology. 2008;74:150–157
  48. Watson WJ. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol. 2005;105:642–643
  49. Fanale MA, Uyei AR, Theriault RL, Adam K, Thompson RA. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer. 2005;6:354–356
  50. Waterston AM, Graham J. Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol. 2006;24:321–322
  51. Kelly H, Graham M, Humes E, Dorflinger LJ, Boggess KA, O’Neil BH, et al. Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clin Breast Cancer. 2006;7:339–341
  52. Bader AA, Schlembach D, Tamussino KF, Pristauz G, Petru E. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol. 2007;8:79–81
  53. Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G. Favorable pregnancy outcome following trastuzumab (Herceptin) use during pregnancy-case report and updated literature review. Reprod Toxicol. 2007;23:611–613
  54. Witzel ID, Müller V, Harps E, Janicke F, Dewit M. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol. 2008;19:191–192
  55. Berveiller P, Mir O, Sauvanet E, Antoine EC, Goldwasser F. Ectopic pregnancy in a breast cancer patient receiving trastuzumab. Reprod Toxicol. 2008;25:286–288
  56. Pant S, Landon MB, Blumenfeld M, Farrar W, Shapiro CL. Treatment of breast cancer with trastuzumab during pregnancy. J Clin Oncol. 2008;26:1567–1569
  57. Weber-Schoendorfer C, Schaefer C. Trastuzumab exposure during pregnancy. Reprod Toxicol. 2008;25:390–391
  58. Warraich Q, Smith N. Herceptin therapy in pregnancy: continuation of pregnancy in the presence of anhydramnios. J Obstet Gynaecol. 2009;29:147–148
  59. Beale JM, Tuohy J, McDowell SJ. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios. Am J Obstet Gynecol. 2009;201:e12–e14
  60. Azim HA, Peccatori FA, Liptrott SJ, Catania C, Goldhirsch A. Breast cancer and pregnancy: How safe is trastuzumab?. Nat Rev Clin Oncol. 2009;6:367–370
  61. Azim H, Azim HA, Escudier B. Trastuzumab versus lapatinib: the cardiac side of the story. Cancer Treat Rev. 2009;35:633–638
  62. Press MF, Cordon-Cardo C. Slamon DJ: expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene. 1990;5:953–962
  63. Iguchi T, Hirokawa M, Takasugi M. Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen. Toxicology. 1986;42:1–11
  64. Tewari K, Bonebrake RG, Asrat T, Shanberg AM. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancer. 1997;350:183
  65. Cullins SL, Pridjian G, Sutherland CM. Goldenhar’s syndrome associated with tamoxifen given to the mother during gestation. J Am Med Assoc. 1994;271:1905–1906
  66. Oksuzoglu B, Guler N. An infertile patient with breast cancer who delivered a healthy child under adjuvant tamoxifen therapy. Eur J Obstet Gynecol Reprod Biol. 2002;104:79
  67. Isaacs RJ, Hunter W, Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy-case report and literature review. Gynecol Oncol. 2001;80:405–408
  68. Barthelmes L, Gateley CA. Tamoxifen and pregnancy. Breast. 2004;13:446–451
  69. Clark S. Prophylactic tamoxifen. Lancet. 1993;342:168
  70. Karimi Zarchi M, Behtash N, Modares Gilani M. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review. Arch Gynecol Obstet. 2008;277:75–78
  71. Hubalek M, Smekal-Schindelwig C, Zeimet AG, Sergi C, Brezinka C, Mueller-Holzner E, et al. Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma. Arch Gynecol Obstet. 2007;276:179–183
  72. Machado F, Vegas C, Leon J, Perez A, Sanchez R, Parrilla JJ, et al. Ovarian cancer during pregnancy: analysis of 15 cases. Gynecol Oncol. 2007;105:446–450
  73. Motegi M, Takakura S, Takano H, Tanaka T, Ochiai K. Adjuvant chemotherapy in a pregnant women with endodermal sinus tumor of the ovary. Obstet Gynecol. 2007;109:537–540
  74. Robova H, Rob L, Hrehorcak M, Zoban P, Prusa R. Endodermal sinus tumor diagnosed in pregnancy: a case report. Int J Gynecol Cancer. 2007;17:914–916
  75. Ghaemmaghami F, Hasanzadeh M. Good fetal outcome of pregnancies with gynecologic cancer conditions: cases and literature review. Int J Gynecol Cancer. 2006;16(Suppl 1):225–230
  76. Han JY, Nava-Ocampo AA, Kim TJ, Shim JU, Park CT. Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant germ cell tumors: report of 2 cases. Reprod Toxicol. 2005;19:557–561
  77. Malhotra N, Sood M. Ovarian germ cell neoplasm in pregnancy. Eur J Gynaecol Oncol. 2000;21:396
  78. Elit L, Bocking A, Kenyon C, Natale R. An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol. 1999;72:123–127
  79. Tomlinson MW, Treadwell MC, Deppe G. Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy. Eur J Gynaecol Oncol. 1997;18:44–46
  80. Horbelt D, Delmore J, Meisel R, Cho S, Roberts D, Logan D. Mixed germ cell malignancy of the ovary concurrent with pregnancy. Obstet Gynecol. 1994;84:662–664
  81. Buller RE, Darrow V, Manetta A, Porto M, DiSaia PJ. Conservative surgical management of dysgerminoma concomitant with pregnancy. Obstet Gynecol. 1992;79:887–890
  82. Christman JE, Teng NN, Lebovic GS, Sikic BI. Delivery of a normal infant following cisplatin, vinblastine, and bleomycin (PVB) chemotherapy for malignant teratoma of the ovary during pregnancy. Gynecol Oncol. 1990;37:292–295
  83. Metz SA, Day TG, Pursell SH. Adjuvant chemotherapy in a pregnant patient with endodermal sinus tumor of the ovary. Gynecol Oncol. 1989;32:371–374
  84. Kim DS, Park MI. Maternal and fetal survival following surgery and chemotherapy of endodermal sinus tumor of the ovary during pregnancy: a case report. Obstet Gynecol. 1989;73:503–507
  85. Rouzi AA, Sahly NN, Sahly NF, Alahwal MS. Cisplatinum and docetaxel for ovarian cancer in pregnancy. Arch Gynecol Obstet. 2009;280:823–825
  86. Tabata T, Nishiura K, Tanida K, Kondo E, Okugawa T, Sagawa N. Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature. Int J Gynecol Cancer. 2008;18:181–184
  87. Mantovani G, Gramignano G, Mais V, Melis GB, Parodo G, Carrucciu GM. Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review. Eur J Obstet Gynecol Reprod Biol. 2007;131:238–239
  88. Modares Gilani M, Karimi Zarchi M, Behtash N, Ghaemmaghami F, Mousavi AS, Behnamfar F. Preservation of pregnancy in a patient with advanced ovarian cancer at 20 weeks of gestation: case report and literature review. Int J Gynecol Cancer. 2007;17:1140–1143
  89. Raghunath RG, Shashi RR, Vijaykumar MA. Chemotherapy for ovarian mucinous cystadenocarcinoma during pregnancy: a case report. J Obstet Gynecol India. 2006;56:446–448
  90. Ferrandina G, Distefano M, Testa A, De Vincenzo R, Scambia G. Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review. Gynecol Oncol. 2005;97:693–696
  91. Picone O, Lhommé C, Tournaire M, Pautier P, Camatte S, Vacher-Lavenue MC, et al. Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review. Gynecol Oncol. 2004;94:600–604
  92. Huang HP, Fang CN, Kan YY. Chemotherapy for ovarian mucinous cyctadenocarcinoma during pregnancy: a case report. Eur J Gynaecol Oncol. 2004;25:635–636
  93. Méndez LE, Mueller A, Salom E, González-Quintero VH. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol. 2003;102:1200–1202
  94. Sood AK, Shahin MS, Sorosky JI. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol. 2001;83:599–600
  95. Otton G, Higgins S, Phillips KA, Quinn M. A case of early-stage epithelial ovarian cancer in pregnancy. Int J Gynecol Cancer. 2001;11:413–417
  96. Ohara N, Teramoto K. Successful treatment of an advanced ovarian serous cystadenocarcinoma in pregnancy with cisplatin, adriamycin and cyclophosphamide (CAP) regimen. Case report. Clin Exp Obstet Gynecol. 2000;27:123–124
  97. Bayhan G, Aban M, Yayla M, Gül T, Yaldiz M, Erden AC. Cis-platinum combination chemotherapy during pregnancy for mucinous cystadenocarcinoma of the ovary. Case report. Eur J Gynaecol Oncol. 1999;20:231–232
  98. Koc ON, McFee M, Reed E, Gerson SL. Detection of platinum-DNA adducts in cord blood lymphocytes following in utero platinum exposure. Eur J cancer. 1994;30A:716–717
  99. Henderson CE, Elia G, Garfinkel D, Poirier MC, Shamkhani H, Runowicz CD. Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary. Gynecol Oncol. 1993;49:92–94
  100. King LA, Nevin PC, Williams PP, Carson LF. Treatment of advanced epithelial ovarian carcinoma in pregnancy with cisplatin-based chemotherapy. Gynecol Oncol. 1991;41:78–80
  101. Malfetano JH, Goldkrand JW. Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma. Obstet Gynecol. 1990;75:545–547
  102. Palaia I, Pernice M, Graziano M, Bellati F, Panici PB. Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer during pregnancy: a case report. Am J Obstet Gynecol. 2007;197:e5–e6
  103. Karam A, Feldman N, Holschneider CH. Neoadjuvant cisplatin and cesarean hysterectomy for cervical cancer in pregnancy. Nat Clin Pract Oncol. 2007;4:375–380
  104. Bader AA, Petru E, Winter R. Long-term follow-up after neoadjuvant chemotherapy for high-risk cervical cancer during pregnancy. Gynecol Oncol. 2007;105:269–272
  105. Benhaim Y, Haie-Meder C, Lhommé C, Pautier P, Duvillard P, Castaigne D, et al. Chemoradiation therapy in pregnant patients treated for advanced-stage cervical carcinoma during the first trimester of pregnancy: report of two cases. Int J Gynecol Cancer. 2007;17:270–274
  106. Caluwaerts S, Van Calsteren K, Mertens L, Lagae L, Moerman P, Hanssens M, et al. Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature. Int J Gynecol Cancer. 2006;16:905–908
  107. Germann N, Haie-Meder C, Morice P, L’homme C, Duvillard P, Hacene K, et al. Management and clinical outcomes of pregnant patients with invasive cervical cancer. Ann Oncol. 2005;16:397–402
  108. Ostrom K, Ben-Arie A, Edwards C, Gregg A, Chiu JK, Kaplan AL. Uterine evacuation with misoprostol during radiotherapy for cervical cancer in pregnancy. Int J Gynecol Cancer. 2003;13:340–343
  109. Marana HR, de Andrade JM, da Silva Mathes AC, Duarte G, da Cunha SP, Bighetti S. Chemotherapy in the treatment of locally advanced cervical cancer and pregnancy. Gynecol Oncol. 2001;80:272–274
  110. Tewari K, Cappuccini F, Gambino A, Kohler MF, Pecorelli S, DiSaia PJ. Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy. Cancer. 1998;82:1529–1534
  111. Lai CH, Hsueh S, Chang TC, Tseng CJ, Huang KG, Chou HH, et al. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol. 1997;64:456–462
  112. Giacalone PL, Laffargue F, Benos P, Rousseau O, Hedon B. Cis-platinum neoadjuvant chemotherapy in a pregnant woman with invasive carcinoma of the uterine cervix. Br J Obstet Gynaecol. 1996;103:932–934
  113. Meazza C, Casanova M, Zaffignani E, Clerici CA, Favini F, Vasquez R, et al. An adolescent with rhabdomyosarcoma during pregnancy. Tumori. 2008;94:431–433
  114. Aboujaoude R, Alvarez JR, Alvarez M, Al-Khan A. Follicular dendritic cell sarcoma in pregnancy: case report and review of the literature. Am J Perinatol. 2006;23:459–461
  115. Nakajima W, Ishida A, Takahashi M, Hirayama M, Washino N, Ogawa M, et al. Good outcome for infant of mother treated with chemotherapy for ewing sarcoma at 25 to 30 week’s gestation. J Pediatr Hematol Oncol. 2004;26:308–311
  116. Merimsky O, Le Cesne A. Soft tissue and bone sarcoma in association with pregnancy. Acta Oncol. 1998;37:721–727
  117. Martin D, Winter SS, Gardner MO, Nicklaus P. Rhabdomyosarcoma treated with chemotherapy during the first trimester. Obstet Gynecol. 1997;89:828–831
  118. Fernandez H, Diallo A, Baume D, Papiernik E. Anhydramnios and cessation of fetal growth in a pregnant mother with polychemotherapy during the second trimester. Prenat Diagn. 1989;9:681–682
  119. Meador JM, Armentrout SA, Slater LM. Third trimester chemotherapy and neonatal hematopoiesis. Cancer Chemother Pharmacol. 1987;19:177–179
  120. Haerr RW, Pratt AT. Multiagent chemotherapy for sarcoma diagnosed during pregnancy. Cancer. 1985;56:1028–1033
  121. Rawlinson KF, Zubrow AB, Harris MA, Jackson UC, Chao S. Disseminated Kaposi’s sarcoma in pregnancy: a manifestation of acquired immune deficiency syndrome. Obstet Gynecol. 1984;63:2S–6S
  122. Blatt J, Mulvihill JJ, Ziegler JL, Young RC, Poplack DG. Pregnancy outcome following cancer chemotherapy. AM J Med. 1980;69:828–832
  123. Ateser G, Yildiz O, Leblebici C, Mandel NM, Unal F, Turna H, et al. Metastatic primitive neuroectodermal tumor of the ovary in pregnancy. Int J Gynecol Cancer. 2007;17:266–269
  124. Azim HA, Scarfone G, Peccatori FA. Carboplatin and weekly paclitaxel for the treatment of advanced non-small cell lung cancer (NSCLC) during pregnancy. J Thorac Oncol. 2009;4:559–560
  125. Gurumurthy M, Koh P, Singh R, Bhide A, Satodia P, Hocking M, et al. Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy. J Perinatol. 2009;29:63–65
  126. García-González J, Cueva J, Lamas MJ, Curiel T, Graña B, López-López R. Paclitaxel and cisplatin in the treatment of metastatic non-small-cell lung cancer during pregnancy. Clin Trans Oncol. 2008;10:375–376
  127. Zambelli A, Prada GA, Fregoni V, Ponchio L, Sagrada P, Pavesi L. Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy. Lung cancer. 2008;60:455–457
  128. Garrido M, Clavero J, Huete A, Sánchez C, Solar A, Alvarez M, et al. Prolonged survival of a woman with lung cancer diagnosed and treated with chemotherapy during pregnancy. Review of cases reported. Lung Cancer. 2008;60:285–290
  129. Kim JH, Kim HS, Sung CW, Kim KJ, Kim CH, Lee KY. Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy. Lung cancer. 2008;59:270–273
  130. Jänne PA, Rodriguez-Thompson D, Metcalf DR, Swanson SJ, Greisman HA, Wilkins-Haug L, et al. Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy. Oncology. 2001;61:175–183
  131. Kluetz PG, Edelman MJ. Successful treatment of small cell lung cancer during pregnancy. Lung Cancer. 2008;61:129–130
  132. Li RH, Tam WH, Ng PC, Mok TS, Tam B, Lau TK. Microphthalmos associated with Dartmouth combination chemotherapy in pregnancy: a case report. J Reprod Med. 2007;52:575–576
  133. Dipaola RS, Goodin S, Ratzell M, Florczyk M, Karp G, Ravikumar TS. Chemotherapy for metastatic melanoma during pregnancy. Gynecol Oncol. 1997;66:526–530
  134. Harkin KP, Drumm JE, O’Brien P, Daly A. Metastatic malignant melanoma in pregnancy. Ir Med J. 1990;83:116–117
  135. Blumenthal DT, Parreño MG, Batten J, Chamberlain MC. Management of malignant gliomas during pregnancy: a case series. Cancer. 2008;113:3349–3354
  136. Gensheimer M, Jones CA, Graves CR, Merchant NB, Lockhart AC. Administration of oxaliplatin to a pregnant woman with rectal cancer. Cancer Chemother Pharmacol. 2009;63:371–373
  137. Kanate AS, Auber ML, Higa GM. Priorities and uncertainties of administering chemotherapy in a pregnant woman with newly diagnosed colorectal cancer. J Oncol Pharm Pract. 2009;15:5–8
  138. Cheung EJ, Wagner H, Botti JJ, Fedok F, Goldenberg D. Advanced oral tongue cancer in a 22-year-old pregnant woman. Ann Otol Rhinol Laryngol. 2009;118:21–26
  139. Raffles A, Williams J, Costeloe K, Clark P. Transplacental effects of maternal cancer chemotherapy. Case report. Br J Obstet Gynaecol. 1989;96:1099–1100
  140. Arango HA, Kalter CS, Decesare SL, Fiorica JV, Lyman GH, Spellacy WN. Management of chemotherapy in a pregnancy complicated by a large neuroblastoma. Obstet Gynecol. 1994;84:665–668
  141. Mir O, Berveiller P, Ropert S, Goffinet F, Goldwasser F. Use of platinum derivatives during pregnancy. Cancer. 2008;113:3069–3074

PII: S0305-7372(09)00181-9

doi: 10.1016/j.ctrv.2009.11.007

Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 101-109 , April 2010

Article Tools